These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 15146825)
1. Clinton-brokered AIDS drug-price agreement to benefit millions. AIDS Policy Law; 2004 Apr; 19(8):1, 4. PubMed ID: 15146825 [No Abstract] [Full Text] [Related]
2. Economic research on HIV prevention, care and treatment: why it is more than ever needed? Moatti JP; Eboko F Curr Opin HIV AIDS; 2010 May; 5(3):201-3. PubMed ID: 20539074 [No Abstract] [Full Text] [Related]
3. Balancing pills and patents: intellectual property and the HIV/AIDS crisis. Nderitu T E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022 [No Abstract] [Full Text] [Related]
4. The fight against HIV/AIDS: opportunities and challenges. Lulseged S; Sanders E Ethiop Med J; 2002 Apr; 40 Suppl 1():2p. PubMed ID: 12802825 [No Abstract] [Full Text] [Related]
5. HIV/AIDS. The great funding surge. Cohen J Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876 [No Abstract] [Full Text] [Related]
6. CalPERS to reopen drug giant's AIDS drug-pricing issue. AIDS Policy Law; 2003 Dec; 18(22):9. PubMed ID: 14974405 [No Abstract] [Full Text] [Related]
7. Essential AIDS medications in India. Thomas J Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350 [No Abstract] [Full Text] [Related]
9. GlaxoSmithKline, under pressure, cuts price of AIDS treatment for poor countries. Fleck F Bull World Health Organ; 2003; 81(6):469. PubMed ID: 12894339 [No Abstract] [Full Text] [Related]
10. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges. Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289 [No Abstract] [Full Text] [Related]
11. Improving access to essential drugs for people living with HIV/AIDS. Balasubramaniam K Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335 [No Abstract] [Full Text] [Related]
12. "No turning back" on cheap AIDS drugs for poor nations, UN vows. Silversides A CMAJ; 2003 Nov; 169(10):1067. PubMed ID: 14609992 [No Abstract] [Full Text] [Related]
13. PEPFAR claims gains in global fight against AIDS. AIDS Policy Law; 2007 May; 22(10):2. PubMed ID: 17619264 [No Abstract] [Full Text] [Related]
14. An unequal activism for an unequal epidemic? Selemogo M Dev World Bioeth; 2005 May; 5(2):153-68. PubMed ID: 15842724 [TBL] [Abstract][Full Text] [Related]
15. Clinton team lowers drug price 7-fold in Caribbean. James JS AIDS Treat News; 2003 Mar; (389):7-8. PubMed ID: 12712939 [TBL] [Abstract][Full Text] [Related]
16. HIV/AIDS. The high cost of stolen funds. Cohen J Science; 2008 Jul; 321(5888):523. PubMed ID: 18653880 [No Abstract] [Full Text] [Related]
17. Top stories of 2007. Sax PE AIDS Clin Care; 2008 Jan; 20(1):1-3. PubMed ID: 18399006 [No Abstract] [Full Text] [Related]
18. Cost-effectiveness of HIV therapies in different economic worlds. Laurence J AIDS Read; 2001 May; 11(5):236-7. PubMed ID: 11392685 [No Abstract] [Full Text] [Related]
19. Africa finds drug giants guilty of excessive pricing. AIDS Policy Law; 2003 Dec; 18(22):5. PubMed ID: 14974397 [No Abstract] [Full Text] [Related]
20. Global AIDS epidemic: getting things done. James JS AIDS Treat News; 2001 Jun; (367):7. PubMed ID: 11548660 [No Abstract] [Full Text] [Related] [Next] [New Search]